4,745 Shares in Astera Labs, Inc. $ALAB Purchased by Wealth Enhancement Advisory Services LLC

Wealth Enhancement Advisory Services LLC bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 4,745 shares of the company’s stock, valued at approximately $431,000.

A number of other large investors also recently modified their holdings of ALAB. Rhumbline Advisers increased its position in Astera Labs by 4.4% during the 1st quarter. Rhumbline Advisers now owns 104,345 shares of the company’s stock valued at $6,226,000 after purchasing an additional 4,396 shares during the period. Farther Finance Advisors LLC grew its holdings in Astera Labs by 198.6% in the first quarter. Farther Finance Advisors LLC now owns 1,284 shares of the company’s stock worth $80,000 after purchasing an additional 854 shares during the period. Wealthcare Advisory Partners LLC increased its position in Astera Labs by 1.1% in the 1st quarter. Wealthcare Advisory Partners LLC now owns 28,939 shares of the company’s stock valued at $1,727,000 after buying an additional 320 shares in the last quarter. GAMMA Investing LLC increased its holdings in shares of Astera Labs by 55.7% during the first quarter. GAMMA Investing LLC now owns 794 shares of the company’s stock valued at $47,000 after acquiring an additional 284 shares in the last quarter. Finally, Simplicity Wealth LLC acquired a new position in Astera Labs during the first quarter worth $859,000. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Trading Up 10.0%

Astera Labs stock opened at $220.81 on Tuesday. The firm has a 50 day simple moving average of $191.76 and a 200 day simple moving average of $120.89. Astera Labs, Inc. has a 1-year low of $47.13 and a 1-year high of $262.90. The firm has a market capitalization of $36.70 billion, a price-to-earnings ratio of 394.30, a P/E/G ratio of 5.09 and a beta of 1.43.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.33 by $0.11. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The firm had revenue of $191.93 million for the quarter, compared to the consensus estimate of $172.46 million. During the same quarter in the prior year, the business posted $0.13 earnings per share. The business’s quarterly revenue was up 149.5% on a year-over-year basis. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. On average, equities research analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current year.

Insider Buying and Selling

In related news, COO Sanjay Gajendra sold 280,000 shares of the business’s stock in a transaction that occurred on Thursday, August 7th. The shares were sold at an average price of $170.02, for a total transaction of $47,605,600.00. Following the completion of the transaction, the chief operating officer owned 5,525,545 shares of the company’s stock, valued at approximately $939,453,160.90. The trade was a 4.82% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Manuel Alba sold 183,000 shares of the company’s stock in a transaction that occurred on Tuesday, September 2nd. The stock was sold at an average price of $173.27, for a total transaction of $31,708,410.00. Following the sale, the director directly owned 385,863 shares in the company, valued at $66,858,482.01. This trade represents a 32.17% decrease in their position. The disclosure for this sale can be found here. Insiders sold 1,492,036 shares of company stock worth $232,607,552 over the last quarter. 12.50% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the stock. Citigroup lifted their price objective on shares of Astera Labs from $160.00 to $275.00 and gave the stock a “buy” rating in a report on Wednesday, September 17th. Susquehanna boosted their target price on Astera Labs from $80.00 to $125.00 and gave the stock a “neutral” rating in a research note on Thursday, August 7th. CICC Research assumed coverage on Astera Labs in a report on Friday, August 29th. They issued an “outperform” rating and a $190.00 target price for the company. Evercore ISI lifted their price target on Astera Labs from $104.00 to $215.00 and gave the stock an “outperform” rating in a report on Wednesday, August 6th. Finally, TD Cowen initiated coverage on Astera Labs in a research report on Wednesday, October 1st. They issued a “hold” rating and a $200.00 price objective on the stock. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat.com, Astera Labs presently has an average rating of “Moderate Buy” and an average target price of $159.83.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.